Surgery hasnt always been an option for metastatic bladder cancer (or bladder cancer thats spread from its original site). But according to limited research, surgical treatments may now help some ...

Whole genome–based ultrasensitive circulating tumor DNA clearance as a biomarker of exceptional outcomes with enfortumab vedotin and pembrolizumab in urothelial carcinoma: Preliminary real-world ...

Circulating tumor DNA, or ctDNA, can predict metastatic risk in patients who receive bladder-sparing treatment for muscle-invasive bladder cancer, but it is not a good predictor of local recurrence ...

Dr. Massimo Alfano, group leader at the Department of Urology at the Ospedale San Raffael In bladder cancer, the unmet need is clear. Surgeons remove what they can see; however, cancer cells smaller ...

There is a time when "tough love" isn't appropriate. And when a spouse, family member or friend is dealing with the consequences of bladder cancer, that is certainly not what is called for. While ...

BUFFALO, N.Y. — Roswell Park Comprehensive Cancer Center announces the release of a new operative surgical manual authored by Khurshid Guru, MD, Chair of Urology and the newly named Dr. Robert P.

FDA authorization extends perioperative pembrolizumab plus enfortumab vedotin to cystectomy-eligible muscle-invasive bladder cancer, removing the prior restriction to cisplatin-ineligible patients.

Dr. David Greenberg outlines bladder cancer staging, BCG, immunotherapy, surgery, quality of life impacts and long-term follow-up care strategies. Bladder cancer treatment depends on whether the ...

Bladder cancer claims 220,000 lives globally each year, with symptoms sometimes mistaken for other conditions such as kidney ...

Comparison of clinicopathological features and prognoses of de-novo metastatic male and female bladder cancer patients. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary Cancers ...